CHICAGO (Reuters) – The judge who will decide if Amgen can go forward with its $27.8 billion purchase of Horizon Therapeutics on Tuesday said he was considering an evidentiary hearing on the matter in September. Judge John Kness said he would likely take about four weeks after the hearing ends…Read More
US judge hearing fight over Amgen deal for Horizon eyes September trial
